Cours MediXall Group, Inc. Other OTC
Actions
MDXL
US58504K1043
Equipement et technologie médicale avancés
CA 2021 | 15 k 13,62 k | CA 2022 | 59,27 k 53,85 k | Capitalisation | 77,59 M 70,5 M |
---|---|---|---|---|---|
Résultat net 2021 | -6 M -5,45 M | Résultat net 2022 | -6 M -5,45 M | VE / CA 2021 | 7 599 x |
Dette nette 2021 | 252 k 229 k | Dette nette 2022 | 2,82 M 2,56 M | VE / CA 2022 | 1 357 x |
PER 2021 |
-17
x | PER 2022 |
-10,5
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 85,16% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Travis Jackson
CEO | Chief Executive Officer | - | 14/06/22 |
Shane Glavin
DFI | Director of Finance/CFO | - | 06/12 |
Frank Dickerson
IRC | Investor Relations Contact | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Marino
CEO | Chief Executive Officer | 52 | 01/06/13 |
Travis Jackson
CEO | Chief Executive Officer | - | 14/06/22 |
Robert Hood
BRD | Director/Board Member | - | 10/10/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+11,29% | 226 Md | |
+8,76% | 188 Md | |
+12,90% | 137 Md | |
+25,95% | 108 Md | |
+0,34% | 63,19 Md | |
+11,08% | 52,26 Md | |
+5,62% | 51 Md | |
+6,28% | 43,89 Md | |
+4,80% | 38,07 Md |